Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe tirzepatide injection is sold in the UK under the brand name Mounjaro, made by Eli Lilly. Every pre-filled pen you receive through a UK pharmacy carries that name on the packaging. Tirzepatide is the active ingredient; Mounjaro is the product. This distinction matters practically, because a prescriber writes for Mounjaro, a pharmacy dispenses Mounjaro, and the clinical trials, the MHRA licence, and the NHS patient information for tirzepatide all sit behind that registered brand. These are prescription-only medicines — a clinician assesses your health before any prescription is written, and suitability is never assumed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When someone searches for the "tirzepatide injection brand name," they are usually trying to confirm one of two things: what to ask a pharmacist for, or whether something they have been offered is legitimate. The answer to the first question is straightforward. Tirzepatide's registered UK brand is Mounjaro. There is no other UK-licensed tirzepatide product for weight management. If a seller describes a tirzepatide pen under a different brand, or without connecting it to Eli Lilly's manufacturing and the UK supply chain, that is worth questioning carefully, the MHRA has warned publicly about counterfeit weight-loss pens circulating through unregistered online sellers.
The name also matters for your records. Your GP, if notified, and any other clinician you see will recognise Mounjaro. Prescriptions, pharmacy labels and clinical correspondence all use the brand name alongside the INN (international non-proprietary name), tirzepatide. You may see both on your packaging, which is normal and correct. For a broader overview of what this treatment involves, our Mounjaro guide covers the full picture.
Mounjaro is supplied as a pre-filled KwikPen. Each pen holds enough medicine for four once-weekly injections, delivered via a fine needle attached at the tip before each use. The available UK strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Treatment starts at 2.5 mg because the body needs time to adjust, and the prescriber moves the dose upward in a schedule they set based on how you are tolerating the medicine.
The pen itself is compact and designed for self-injection. If you order through a regulated pharmacy, you will typically receive it in plain, unbranded outer packaging, a DPD tracking notification on your phone will alert you before it arrives, so you are not leaving a medicine that needs refrigeration on a doorstep. Once you open the box, the Mounjaro pen and leaflet are inside, along with any needles included by the pharmacy. Some people find it helpful to read the step-by-step injection technique guidance before their first dose, particularly around site rotation and the mechanics of the KwikPen. Details on the right needle for each injection are worth reviewing at our needle information page.
Mounjaro received its UK marketing authorisation from the MHRA for weight management in adults with a BMI of 30 or above, or 27 and above where at least one weight-related health condition is present. The clinical programme that underpinned that licence was substantial: the SURMOUNT-1 trial alone randomised 2,539 adults and ran for 72 weeks, reporting average body-weight reductions of around 20 to 21 per cent at the 15 mg dose. NICE subsequently appraised the evidence and recommended tirzepatide for NHS use in a phased rollout, detailed in NICE technology appraisal TA1026.
Mounjaro carries the Black Triangle designation, which means the MHRA has asked prescribers and patients to report any suspected side effects through the Yellow Card scheme. This is not a signal that the medicine is unsafe, it is a standard requirement for recently licensed medicines so that real-world safety data can accumulate. Common side effects are gastrointestinal: nausea, loose stools and indigestion are the ones most frequently reported, usually most noticeable in the early weeks. For information on how the injection process feels and what to expect dose to dose, the injecting tirzepatide page goes through the practical detail.
Knowing the brand name is one of the first checks in confirming a legitimate supply. Genuine Mounjaro comes from the licensed UK supply chain, dispensed by pharmacies registered with the General Pharmaceutical Council. You can verify any online pharmacy at the GPhC pharmacy register, it takes about thirty seconds and gives you confidence that the organisation dispensing to you is regulated and inspected. A pharmacy that cannot be found on that register should not be dispensing prescription medicines.
The cost of tirzepatide is a fair question, and one covered in more depth on our treatment and pricing page. What matters here is that the brand name on the pen (Mounjaro, from Eli Lilly) is not interchangeable with a generic or a compound. There is currently no licensed generic tirzepatide injection in the UK. If you have questions about what the tirzepatide pen looks like in practice, or how to handle and store it correctly, the Mounjaro pen page covers those specifics, and our Mounjaro injection overview addresses the injection process from a broader perspective.
If you would like a prescriber to assess your suitability for Mounjaro, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not an automated system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.